Thursday, April 7, 2011

Goldis surges on stake sale for RM289m to Japan's Taisho Pharmaceutical

KUALA LUMPUR: Shares of Goldsis Bhd surged in afternoon trade n Thursday, April 7 after it announced the proposed sale of its entire 78.15% stake in Hoepharma Holdings Sdn Bhd for RM289 million.

Its shares jumped 33 sen to RM1.90 with 493,300 shares done at 2.40pm.

The FBM KLCI was up 3.13 points to 1,556.02. Turnover was 893.46 million shares valued at RM1.09 billion. There were 392 gainers, 298 gainers and 326 stocks unchanged.

Investors viewed the disposal as positive for Goldis to focus on its core business.

Goldsis said it was selling its entire 78.15% stake in Hoepharma for RM289 million to Tokyo listed Taisho Pharmaceutical Co.

Six other individuals who collectively own the remaining 21.85% stake in Hoepharma were also disposing of their shares for RM81 million.

As at the financial year ended Jan 31, 2011, Hoepharma had deposits of about RM9.8 million in addition to cash and bank balances of about RM12.9 million. HOE Pharmaceuticals Sdn Bhd, a unit of Hoepharma owns seven shop lots with strata titles.

No comments:

Post a Comment